Guido Rindi

Medicine & Life Sciences

1. Neuroendocrine Tumors 100%
2. Neoplasms 45%
3. Neuroendocrine Carcinoma 39%
4. Needles 36%
5. Carcinoid Tumor 35%
6. 68Ga-DOTANOC 28%
7. Cell Biology 25%
8. Lung 22%
9. Pancreatic Neoplasms 22%
10. Pituitary Neoplasms 21%
11. Guidelines 19%
12. Large Cell Carcinoma 17%
13. pasireotide 17%
14. Histology 16%
15. Somatostatin 16%
16. Squamous Cell Carcinoma 16%
17. Fluorodeoxyglucose F18 16%
18. Fine Needle Biopsy 15%
19. Neoplasm Metastasis 14%
20. Pancreas 13%
21. Somatostatin Receptors 13%
22. Prospective Studies 12%
23. lanreotide 12%
24. Neck 11%
25. Head 11%
26. Adenocarcinoma 11%
27. Adenocarcinoma of Lung 11%
28. Immunohistochemistry 11%
29. 68Ga-DOTA-Peptide 10%
30. Galectin 3 10%
31. Cohort Studies 9%
32. Acromegaly 9%
33. Gastrointestinal Stromal Tumors 9%
34. Lung Neoplasms 9%
35. Multicenter Studies 9%
36. Positron Emission Tomography Computed Tomography 8%
37. Papillomavirus Infections 8%
38. pegvisomant 8%
39. Pathologists 8%
40. Biopsy 8%
41. Growth Hormone-Secreting Pituitary Adenoma 8%
42. Multiple Endocrine Neoplasia Type 1 8%
43. Thyroid Neoplasms 7%
44. Mutation 7%
45. Therapeutics 7%
46. SARS Virus 7%
47. Gastrointestinal Tract 7%
48. Pathology 7%
49. Oropharynx 7%
50. Endoscopic Ultrasound-Guided Fine Needle Aspiration 7%